In this issue of Blood , Cibeira et al report long-term outcomes of 421 patients with AL amyloidosis undergoing autologous stem cell transplantation (ASCT) at a single center.[1][1] Patients who achieved a complete hematologic response (CR) had impressively long hematologic remission, event-free
No takes yet. Share an insight, caveat, or question.
Ashutosh Wechalekar (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: